Phase II study of sorafenib in advanced salivary adenoid cystic carcinoma: Initial outcome and toxicity

Category Primary study
JournalRadiotherapy and Oncology
Year 2012
This article has no abstract
Epistemonikos ID: d0722d30e43b2b07a3db5f95b459fbbd7f66f132
First added on: Feb 05, 2025